Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

BDX - Becton Dickinson & Co.


Close
242.41
1.440   0.594%

Share volume: 893,412
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$240.97
1.44
0.60%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
47%
Profitability 31%
Dept financing 50%
Liquidity 15%
Performance 70%
Company vs Stock growth
vs
Performance
5 Days
2.55%
1 Month
0.28%
3 Months
7.32%
6 Months
2.18%
1 Year
-12.17%
2 Year
-1.33%
Key data
Stock price
$242.41
P/E Ratio 
49.59
DAY RANGE
$240.29 - $242.61
EPS 
$4.84
52 WEEK RANGE
$218.75 - $274.17
52 WEEK CHANGE
-$0.12
MARKET CAP 
70.067 B
YIELD 
1.54%
SHARES OUTSTANDING 
289.042 M
DIVIDEND
$0.95
EX-DIVIDEND DATE
06/10/2024
NEXT EARNINGS DATE
11/07/2024
BETA 
0.42
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$876,727
AVERAGE 30 VOLUME 
$1,122,208
Company detail
CEO: Thomas Polen
Region: US
Website: https://www.bd.com/
Employees: 77,000
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.

Recent news